Suppression of endotoxin- and staphylococcal exotoxin-induced cytokines and chemokines by a phospholipase C inhibitor in human peripheral blood mononuclear cells

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 2, 2001, Pages 449-453

  Krakauer, T ^a  

^a USAMR1ID ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTOXIN; EXOTOXIN; LIPOPOLYSACCHARIDE; PHOSPHOLIPASE C INHIBITOR; STAPHYLOCOCCUS TOXIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; SEPTIC SHOCK;

BRIDGED COMPOUNDS; CHEMOKINE CCL2; CYTOKINES; EXOTOXINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEIN-1; PHOSPHODIESTERASE INHIBITORS; PHOSPHOLIPASE C; SHOCK, SEPTIC; THIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035102695     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.2.449-453.2001     Document Type: Article

References (22)

1. P55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: A randomized controlled multicenter clinical trial
2. Toxic shock syndrome toxin
3. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock
4. Signal transduction of microbial superantigens via MHC class II molecules
5. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells
6. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial
7. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein
8. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR
9. Direct binding of secreted TCR β chain to superantigen associated with MHC class II complex protein
10. Superantigens and their potential role in human disease
11. Inhibition of toxic shock syndrome toxin-induced cytokine production and T cell activation by interleukin 10, interleukin 4, and dexamethasone
12. Proinflammatory cytokines: TNF and IL-1 families, chemokines, TGFβ and others
13. Induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline
14. Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C
15. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
16. T cell-mediated lethal shock triggered in mice by the superantigen SEB: Critical role of TNF
17. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages
18. Endotoxins and disease mechanisms
19. Toxic shock syndrome toxin-1 binds to major histocompatibility complex class II molecules
20. Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C
21. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin
22. Chemokines are the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin